It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2022.
2022 | Hyderabad, Telangana, India | ActiveSibira Pharma Private Limited, a active private limited company, was established on 05 September 2022 in Hyderabad, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239TG2022PTC166314. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Divya Balasubramanian (Director), Bandi Chandana (Additional Director), Payel Sarkar (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at H No.1119 &1121, Sy No.165, Phase-V Dhoolapally Road, Adj. Jeedimetla, Hyderabad, Telangana, 500055.
U24239TG2022PTC166314
166314
05 September 2022
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sibira Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Divya Balasubramanian | Director | 05 Sep 2022 | Current |
| Bandi Chandana | Additional Director | 27 Jan 2024 | Current |
| Payel Sarkar | Director | 05 Sep 2022 | Current |
| Sangarappan Sivakumar | Director | 05 Sep 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Sibira Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Sibira Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Sibira Pharma has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sibira Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sibira Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Bandi Chandana was appointed as a Additional Director was appointed as a Additional Director on 27 Jan 2024 & has been associated with this company since 1 year 10 months . was completed.
Progress on Sibira Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Sibira Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was recorded as a recent event.
The activity Divya Balasubramanian was appointed as a Director was appointed as a Director on 05 Sep 2022 & has been associated with this company since 3 years 2 months . was completed.
Payel Sarkar was appointed as a Director was appointed as a Director on 05 Sep 2022 & has been associated with this company since 3 years 2 months . was recorded as a recent event.
Progress on Sangarappan Sivakumar was appointed as a Director was appointed as a Director on 05 Sep 2022 & has been associated with this company since 3 years 2 months . was documented.
The CIN of Sibira Pharma Private Limited is U24239TG2022PTC166314.
Sibira Pharma Private Limited is headquartered at H No.1119 &1121, Sy No.165, Phase-V Dhoolapally Road, Adj. Jeedimetla, Hyderabad, Telangana, 500055.
Sibira Pharma Private Limited was incorporated on 05 September 2022.
The current directors of Sibira Pharma Private Limited are
The primary industry of Sibira Pharma Private Limited is Chemicals.
Sibira Pharma Private Limited is unlisted.
The authorized capital of Sibira Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX